OSURNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ORASURE TECHNOLOGIES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$3.68+0.07 (+1.94%)
Close on Oct 19, 2026
- Market cap
- $258.18M
- P/E (TTM)
- –
- Dividend yield
- –
ORASURE TECHNOLOGIES INC revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Products and services | $106.31M | $106.43M | $109.06M | $121.41M | $135.73M | $159.83M | $184.61M | $222.94M | $272.30M | $303.09M | $402.22M | $447.49M | 94.6% | -21.7% |
| Other | $6.10M | $6.58M | $5.97M | $4.29M | $2.81M | $1.80M | $1.22M | $1.33M | $1.24M | $1.55M | $3.25M | $5.18M | 5.4% | +117.4% |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $76.75M | $76.37M | $78.25M | $83.96M | $89.65M | $114.18M | $139.16M | $179.80M | $232.37M | $261.85M | $361.66M | $409.77M | 68.3% | -14.4% |
| Africa | $23.41M | $24.65M | $23.99M | $29.39M | $35.89M | $34.23M | $32.75M | – | – | – | – | – | 20.8% | -34.8% |
| Europe | $6.82M | $7.20M | $7.39M | $7.59M | $8.41M | $8.46M | $8.42M | $7.71M | $7.57M | $7.86M | $8.11M | $8.90M | 6.1% | -18.9% |
| Other regions | $5.44M | $4.81M | $5.38M | $4.77M | $4.58M | $4.76M | $5.50M | $13.32M | $21.53M | $29.22M | $6.45M | $33.99M | 4.8% | +18.6% |
From the segment and revenue-disaggregation notes of Orasure Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.